Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2009 Jul 15;50(12):5601–5608. doi: 10.1167/iovs.09-3729

Figure 2.

Figure 2

Subanalysis of the HSV-1 DNA mean copy number in three groups by (A) morning and evening swabs from tears and saliva of subjects from all three groups. (B) Subject with or without history of herpes lesions, and (C) subjects seropositive or seronegative by ELISA and neutralization assay. VCV 500 mg was given once daily and 350 mg aspirin was given twice daily. The number of subjects in the placebo, VCV, and VCV+aspirin groups was 14, 15, and 16, respectively.